| Literature DB >> 34063540 |
Lorenzo Costa1, Tom P C Schlosser1, Hanad Jimale1, Jelle F Homans1, Moyo C Kruyt1, René M Castelein1.
Abstract
Brace treatment is the most common noninvasive treatment in adolescent idiopathic scoliosis (AIS); however it is currently not fully known whether there is a difference in effectiveness between brace types/concepts. All studies on brace treatment for AIS were searched for in PubMed and EMBASE up to January 2021. Articles that did not report on maturity of the study population were excluded. Critical appraisal was performed using the Methodological Index for Non-Randomized Studies tool (MINORS). Brace concepts were distinguished in prescribed wearing time and rigidity of the brace: full-time, part-time, and night-time, rigid braces and soft braces. In the meta-analysis, success was defined as ≤5° curve progression during follow-up. Of the 33 selected studies, 11 papers showed high risk of bias. The rigid full-time brace had on average a success rate of 73.2% (95% CI 61-86%), night-time of 78.7% (72-85%), soft braces of 62.4% (55-70%), observation only of 50% (44-56%). There was insufficient evidence on part-time wear for the meta-analysis. The majority of brace studies have significant risk of bias. No significant difference in outcome between the night-time or full-time concepts could be identified. Soft braces have a lower success rate compared to rigid braces. Bracing for scoliosis in Risser 0-2 and 0-3 stage of maturation appeared most effective.Entities:
Keywords: adolescent idiopathic scoliosis; brace concepts; brace therapy; meta-analysis; night time brace; rigid brace; systematic review
Year: 2021 PMID: 34063540 PMCID: PMC8156678 DOI: 10.3390/jcm10102145
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Strategy of the search in PubMed and Embase. There was no language restriction. Duplicates were removed in Rayyan [17].
| PubMed | (((scoliosis [MeSH Terms] OR scolio * [Title/Abstract] OR spinal curvature [Title/Abstract] OR AIS [Title/Abstract]))) AND ((((brace [MeSH Terms] OR brace [Title/Abstract] OR bracing [Title/Abstract]))) AND ((time [Title/Abstract] OR parttime [Title/Abstract] OR nighttime [Title/Abstract] OR compliance [MeSH Terms] OR compliance [Title/Abstract] OR compliant [Title/Abstract] OR effect [Title/Abstract] OR treatment * [Title/Abstract] OR result [Title/Abstract] OR results [Title/Abstract] OR therap [Title/Abstract] OR mental disorder [Title/Abstract] OR hypersensitive [Title/Abstract] OR peer problem [Title/Abstract] OR depress [Title/Abstract]) OR psychologic [Title/Abstract] OR quality of life [Title/Abstract] OR quality of life [MeSH] OR life quality [Title/Abstract])))). |
| Medscape | (‘scoliosis’: exp OR ‘scolio *’: ti, ab, kw OR ‘spinal curvature *’: ti, ab, kw OR ‘AIS’: ti, ab, kw) AND (‘brace’: exp OR ‘brace *’: ti, ab, kw OR ‘braci *’: ti, ab, kw) AND (‘time’: ti, ab, kw OR ‘parttime’: ti, ab, kw OR ‘nighttime’: ti, ab, kw OR ‘compliance’: exp OR ‘compliance’: ti, ab, kw OR ‘compliant’: ti, ab, kw OR ‘effect *’: ti, ab, kw OR ‘treatment *’: ti, ab, kw OR ‘result’: ti, ab, kw OR ‘results’: ti, ab, kw OR ‘therap *’: ti, ab, kw OR ‘mental disorder *’: ti, ab, kw OR ‘hypersensitiv *’: ti, ab, kw OR ‘peer problem *’: ti, ab, kw OR ‘depress *’: ti, ab, kw OR ‘psychologic *’: ti, ab, kw OR ‘quality of life’: ti, ab, kw OR ‘quality of life’: exp OR ‘life quality’: ti, ab, kw) |
Details regarding inclusion criteria.
|
| Design | Longitudinal studies with at least one-year follow-up from brace initiation |
|
| Population | Patients with adolescent idiopathic scoliosis |
|
| Intervention | Specification of the concept(s) of brace (prescribed wearing time(s) and brace type(s)) used |
|
| Outcome | A definition of success rate (all definitions of success rate were accepted in the qualitative synthesis in this review) |
The MINOR tool [15]. Items 1–8 are for both comparative and non-comparative studies. Items 9–12 are only for comparative studies. The items are scored 0 (not reported), 1 (reported but inadequate), or 2 (reported and adequate), the global ideal score being 16 for non-comparative studies and 24 for comparative studies. For comparative studies: <12 high risk of bias, 12–16 medium risk of bias, >16 low risk of bias. For non-comparative studies: <7 high risk of bias, 7–11 medium risk of bias, >11 low risk of bias.
| 1 | A clearly stated aim | The question address should be precise and relevant. |
| 2 | Inclusions of consecutive patients | All patients potentially fit for inclusion had been included in the study. |
| 3 | Prospective collection data | Data were collected according to a protocol established before the beginning of the study. |
| 4 | Endpoints appropriate to the aim of the study | Unambiguous explanation of the criteria used to evaluate the main outcome. |
| 5 | Unbiased assessment of the study endpoint | Blind evaluation of objective end-points and double blind-evaluation of subjective endpoints. Other explanation of the reasons for not blinding. |
| 6 | Follow-up period appropriate to the aim of the study | The follow-up should be should be sufficiently long to allow the assessment of the main end-points. |
| 7 | Loss to follow-up less than 5% | All patients should be included in the follow-up. Otherwise, the proportion lost should not exceed the proportion experiencing the major end-points. |
| 8 | Prospective calculation of the study size | Information of the size of detectable difference of interest with a calculation of 95% confidence interval. |
| 9 | An adequate control group | Having a gold standard diagnostic test or therapeutic intervention recognized as the optimal intervention according to the available published data. |
| 10 | Contemporary groups | Control and studied group should be managed during the same time period. |
| 11 | Baseline equivalence of groups | The groups should be similar regarding criteria and studied end-point. |
| 12 | Adequate statistical analysis | Whether the statistics were in accordance with the type of study with calculation of confidence interval or relative risk. |
Figure 1Flowchart of literature search.
Overview of the different braces included in this systematic review.
| Brace Type | Rigidity | Prescribed Wearing Time |
|---|---|---|
| Boston [ | Rigid brace | Full-time/part-time |
| Cheneau brace [ | Rigid brace | Full-time/part-time |
| PASB (Progressive Action Short Brace) [ | Rigid brace | Full-time |
| Lyon brace [ | Rigid brace | Full-time |
| Gensingen Brace [ | Rigid brace | Full-time |
| OMC (Osaka Medical College) brace [ | Rigid brace | Full-time |
| Pressure-adjustable orthosis [ | Rigid brace | Full-time |
| Charleston brace [ | Rigid brace | Night-time |
| Providence brace [ | Rigid brace | Night-time |
| SpineCor [ | Soft brace | Full-time |
Overview of the non-comparative studies. The studies lightened in bold are the ones included in the meta-analysis.
| First Author | Year | Risk of Bias | Sample Size | Cobb Angle | Skeletal Maturity | Type of Brace | Brace | Timing | Follow-Up | Definition of Success Rate | Success Rate |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Weinstein [ | 2014 | 14/24 | 146 | 20–40 | Risser 0–2 | Rigid | TLSO | Full-time | 7 years | >50° | 72% |
| 96 | Control group | 42% | |||||||||
|
|
|
|
|
|
|
|
|
|
|
| |
| Yrjonen [ | 2007 | 10/24 | 51 | >25° | Risser 0–3 | Rigid | Boston brace | Full-time | > 1 year | ≤5° | Girls 78.4% |
| 51 | Boys 62.7% | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
| |
| Pasquini [ | 2016 | 5/16 | 843 | 20–40 | Risser 0–2 | Rigid | modified Cheneau brace | Full-time | ≥2 years | ≤5° | 81% |
| Fang [ | 2015 | 10/16 | 32 | 25–40 | Risser 0–2 | Rigid | Cheneau brace | Full-time | 2 years | no curve progression ≥ 50° | 81% |
| Pham [ | 2007 | 7/16 | 63 | 20–45 | Risser 0–2 | Rigid | Cheneau brace | Full-time | 2 years after discontinuing brace therapy | <10° | 85.7% |
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
| |
| Aulisa [ | 2009 | 6/16 | 50 | 25–40 | Risser 0–2 | Rigid | PASB | Full-time | > 2 years | ≤5° | 100% |
|
|
|
|
|
|
|
|
|
|
| ||
| Aulisa [ | 2015 | 4/16 | 69 | 25–40 | Risser 0–2 | Rigid | Lyon brace | Full-time | 2 years | ≤5° | 98.5% |
|
|
|
|
|
|
|
|
|
|
|
| |
| Kuroki [ | 2015 | 10/16 | 31 | 20–40 | Risser 0–2 | Rigid | OMC brace | Full-time | 2 years after discontinuing brace therapy | no curve progression ≥ 50° | 67.8% |
| Yangmin Lin [ | 2020 | 6/16 | 24 | 20–40 | Risser 0–2 | Rigid | Pressure-adjustable orthosis | 1 year | ≤5° | 100% | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Davis [ | 2019 | 6/16 | 56 | 25–40 | Risser 0–2 | Rigid | Providence brace | Night-time | mean 2.21 years | ≤5° | 51.8% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Bohl [ | 2014 | 6/16 | 34 | 25–40 | Risser 0–2 | Rigid | Providence brace | Night-time | 2 years after maturity | ≤5° or >45 degrees | 50% >5°, 59% >45° |
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
Overview of the comparative studies between braces. The studies lightened in bold are the ones included in the meta-analysis.
| First Author | Year | Risk of Bias | Sample Size | Cobb Angle | Skeletal Maturity | Type of Brace | Brace | Timing | Follow-Up | Definition of Success Rate | Success Rate |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Minsk [ | 2017 | 11/24 | 13 | 25–40 | Risser 0–2 | Rigid | Rigo- Cheneau | Full-time | >1 year | ≤5°; no need of surgery | Spinal surgery: 0% |
| 93 | Boston | Spinal surgery: 34% | |||||||||
| Hanks [ | 1988 | 11/24 | 75 | >25 | Risser 0–4 | Rigid | Wilmington Jacket | Full-time | 1 year after discontinuing brace | <10° | Full-time 80% |
| 25 | Part-time | 84% | |||||||||
| Katz [ | 2010 | 11/24 | 57 | 25–40 | Risser 0–2 | Rigid | Boston brace | Full-time | >1 year | ≤5° | 82% > 12 h |
| 43 | Part-time | 31% > 7 h | |||||||||
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
| |||||||
| Janicki [ | 2007 | 10/24 | 35 | 25–40 | Risser 0–2 | Rigid | Providence brace | Night-time | >2 years | ≤5° | 31% |
| 48 | Rigid | Custom TLSO | Full-time | 15% | |||||||
| Ohrt-Nissen [ | 2019 | 13/24 | 40 | 25–40 | Risser 0–2 | Rigid | Providence brace | Night-time | 2 years | ≤5° (primary outcome); curve progression ≥45° | 45% |
| 37 | Rigid | Boston brace | Full-time | 38% | |||||||
| Weiss [ | 2005 | 8/24 | 12 | 15-30 and >30 for rigid brace | Risser sign 0 (one exeption with 1) Tanner 2 or 3 | Soft | SpineCor | Full-time | mean 3.5 years | ≤5° | 8% |
| 10 | Rigid | Cheneau brace | Full-time | 80% | |||||||
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
Figure 2Forest plot of the studies divided per type of concept. Control groups were selected based on type of scoliosis (AIS). A success rate (≤5°) and reviews or case reports (<10 pt.) were excluded. The red line represents successes in the case control group (50%) [4,5,22,24,28,31,34,35,37,39,40,41,44,45,46,51].
Figure 3The bubble graph represents the proportion of the population with less than 5° Cobb angle progression (Y axis) relative to the MINORS score (X axis) and sample size (diameter of the circle). Thirteen non-comparative studies are represented in (a) and three comparative studies in (b). The grey color represents the rigid full-time concept, the red color the night-time concept, the green one the soft concept, and the orange color represents the control group [4,5,22,24,28,31,34,35,37,39,40,41,44,45,46,51].
Figure 4Mean success rate related to maturity. All studies used the Risser sign for assessment of skeletal maturity for initiation of brace treatment and used ≤5° as definition of successful treatment.